The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of CPX-351 in younger patients < 60 years old with secondary acute myeloid leukemia: An updated analysis.
 
Amanda Cecile Przespolewski
No Relationships to Disclose
 
Chetasi Talati
Honoraria - Celgene
 
Salman Fazal
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Novartis
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Novartis; Takeda
 
Pankit Vachhani
No Relationships to Disclose
 
Srinivasa Sanikommu
No Relationships to Disclose
 
Swapna Thota
Honoraria - Incyte
Speakers' Bureau - Incyte
 
Jeffrey Baron
No Relationships to Disclose
 
Elizabeth A. Griffiths
Honoraria - Alexion Pharmaceuticals; Celgene; Newlink Genetics; Otsuka
Research Funding - Astex Pharmaceuticals; Genentech; Novartis; Onconova Therapeutics
 
James E. Thompson
No Relationships to Disclose
 
Kendra Lynn Sweet
Leadership - Immtech (I)
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Agios; Novartis; Otsuka; Pfizer
Speakers' Bureau - Celgene; Jazz Pharmaceuticals; Novartis
Research Funding - Incyte (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Otsuka; Pfizer
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Amgen; Arog; Immunogen; Pfizer; Spectrum Pharmaceuticals
Speakers' Bureau - Incyte; Jazz Pharmaceuticals; Novartis
Research Funding - Immunogen (Inst)